Assessing gait, balance, and muscle strength among breast cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): study protocol for a randomized controlled clinical trial

Assessing gait, balance, and muscle strength among breast cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): study protocol for a randomized controlled clinical trial

Abstract Background Chemotherapy-induced peripheral neuropathy (CIPN) is a common and understudied consequence of taxane chemotherapy for breast cancer treatment. CIPN symptoms include numbness combined with tingling sensations, persistent shooting, stabbing, or burning pain even in the absence of p...

Full description

Bibliographic Details
Main Authors: Patricia Teran-Wodzinski, Douglas Haladay, Tuan Vu, Ming Ji, Jillian Coury, Alana Adams, Lauren Schwab, Constance Visovsky
Format: Article
Language:English
Published: BMC 2022-04-01
Series:Trials
Subjects:
Therapeutic exercise
Chemotherapy-induced peripheral neuropathy
Breast cancer
Online Access:https://doi.org/10.1186/s13063-022-06294-w

Internet

https://doi.org/10.1186/s13063-022-06294-w

Similar Items